Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yasmina Modena"'
Autor:
Elisa Sottotetti, Yasmina Modena, Marina Chiara Garassino, Filippo de Braud, Luca Porcu, Ugo Pastorino, Luigi Cavanna, Giuseppe Lo Russo, Federico Nichetti, Francesca Spinnato, Manlio Mencoboni, Alessandro Del Conte, Anna Paola Fraccon, Alessandro Tuzi, Daniele Pozzessere, Rosaria Gallucci, Emanuela Vattemi, Saverio Cinieri, Claudia Proto, Francesco Verderame, Diego Signorelli, Luca Giacomelli, Carla Verri, Alessandro Bertolini, Mattia Boeri, Marco Platania, Felice Pasini, Valter Torri, Paola Antonelli, Gabriella Sozzi, Antonia Martinetti, Luciana Irtelli
Publikováno v:
Lung Cancer. 132:17-23
Background Oral vinorelbine administered at the maximum tolerated dose has already showed activity and a good safety profile in advanced non-small-cell lung cancer (NSCLC). The MA.NI.LA study was a phase II, multicenter, randomized, controlled trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a974129ffbe26e665c31066664550c
https://doi.org/10.1016/j.lungcan.2019.04.001
https://doi.org/10.1016/j.lungcan.2019.04.001
Autor:
Cristina Falci, Cristina Oliani, Yasmina Modena, Barbara Corso, Caterina Modonesi, Silvia Toso, Donatella Da Corte Z, Elisabetta Cretella, AnnaPaola Fraccon, Antonella Brunello, Romana Segati, Laura Bertolaso, Milena Gusella, Carmen Barile, Roberto Padrini, Felice Pasini, Giovanni De Rosa, Nadia Minicuci
Publikováno v:
Pharmacology Research & Perspectives
In previous studies, steady‐state Z‐endoxifen plasma concentrations (ENDOss) correlated with relapse‐free survival in women on tamoxifen (TAM) treatment for breast cancer. ENDOss also correlated significantly with CYP2D6 genotype (activity scor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b87bb551da3ef263348583e31cb5fd
https://pubmed.ncbi.nlm.nih.gov/32813313
https://pubmed.ncbi.nlm.nih.gov/32813313
Autor:
Yasmina Modena, E. Pezzolo, Carmen Barile, F Pasini, Giorgio Crepaldi, Milena Gusella, Daniela Menon, F. La Russa, Anna Paola Fraccon
Publikováno v:
The Pharmacogenomics Journal. 18:14-22
The role of genetic molecular markers in neoadjuvant treatment for locally advanced esophageal cancer has been reviewed, focusing strictly on concurrent chemoradiation protocols followed by surgery. Eleven studies evaluated the role of mRNA expressio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2cc1636122eb8794e07b0fb3b79fb65
https://doi.org/10.1038/tpj.2017.25
https://doi.org/10.1038/tpj.2017.25
Autor:
P. Paganin, G. De Manzoni, E. Pezzolo, Jacopo Weindelmayer, Daniela Menon, Milena Gusella, Simone Giacopuzzi, F Pasini, Andrea Zanoni, Giorgio Crepaldi, Yasmina Modena, Laura Bertolaso
Publikováno v:
The Pharmacogenomics Journal. 17:252-257
Candidate genes involved in DNA repair, 5-fluorouracil metabolism and drug detoxification were genotyped in 124 patients receiving neoadjuvant chemoradiation treatment for locally advanced esophageal cancer and their predictive role for long-term rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5a1f35cc90980d87a796793d3efd923
https://doi.org/10.1038/tpj.2016.9
https://doi.org/10.1038/tpj.2016.9
Autor:
Felice Pasini, Daniela Menon, Carmen Barile, Donatella Caruso, Laura Bertolaso, Giuseppe Corona, Yasmina Modena, Giorgio Crepaldi, A. Bononi, Anna Paola Fraccon, Milena Gusella, Giorgia Anna Telatin, Roberto Spezzano, Roberto Padrini
Publikováno v:
Cancer chemotherapy and pharmacology. 83(3)
This study investigated correlations of the clinical outcomes of oral metronomic vinorelbine (VNR) with VNR pharmacokinetics and MDR1 polymorphisms. Eighty-two patients with metastatic non-small cell lung cancer (NSCLC) unfit for standard chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff10d076263c5a34ef7ef12dca0c7c89
https://pubmed.ncbi.nlm.nih.gov/30542768
https://pubmed.ncbi.nlm.nih.gov/30542768
Autor:
Milena Gusella, A. Bononi, Carmen Barile, Felice Pasini, Yasmina Modena, Donatella Caruso, Francesca La Russa, Roberto Padrini, Laura Bertolaso, Giuseppe Corona, Anna Paola Fraccon, Daniela Menon, Giorgio Crepaldi, Roberto Spezzano
Publikováno v:
Investigational new drugs. 36(5)
Background Oral metronomic therapy (OMV) is particularly suitable for palliative care, and schedules adapted for unfit patients are advisable. This study investigated the effects of oral vinorelbine given every other day without interruption and its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9646c011ac3ca839b0022f2cdb65f456
https://pubmed.ncbi.nlm.nih.gov/29956056
https://pubmed.ncbi.nlm.nih.gov/29956056
Publikováno v:
Adenocarcinoma of the Esophagogastric Junction ISBN: 9783319287744
In the past decades, survival improvement was overall modest with conventional chemotherapy regimens, and 2-year survival rate did not exceed the 20 %.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f358c2b533a102819994e8916148d01
https://doi.org/10.1007/978-3-319-28776-8_22
https://doi.org/10.1007/978-3-319-28776-8_22
Autor:
Francesca La Russa, Milena Gusella, Simone Giacopuzzi, Anna Paola Fraccon, Giovanni de Manzoni, Yasmina Modena, Maria Bencivenga, Felice Pasini
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 20(1)
Despite improvements in systemic chemotherapy (CT), the prognosis of metastatic adenocarcinoma of the gastroesophageal junction remains poor. Over the years, new targeting agents have become available and were tested, with or without CT, in first or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0529e6b5eef5f24ae988c763a519596a
https://pubmed.ncbi.nlm.nih.gov/27568322
https://pubmed.ncbi.nlm.nih.gov/27568322
Autor:
A. Bononi, Milena Gusella, Carmen Barile, C Bolzonella, Laura Stievano, Giorgio Crepaldi, Daniela Menon, Silvia Toso, Roberto Padrini, Yasmina Modena, Silvia Meneghetti, Felice Pasini
Publikováno v:
British Journal of Clinical Pharmacology. 71:437-444
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Gemcitacine is taken up by the cell through various nucleoside transporters of either the concentrative (CNT) or equilibrative type (ENT) and is then transformed into the inactive metabolite, dFdU, by cyti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::392c9c1ac8aeab3bfb1e05a9400f7782
https://doi.org/10.1111/j.1365-2125.2010.03838.x
https://doi.org/10.1111/j.1365-2125.2010.03838.x
Autor:
Elisa Sottotetti, Marco Platania, Valter Torri, Luca Porcu, Filippo de Braud, Felice Pasini, Alessandro Del Conte, Daniele Pozzessere, Francesco Verderame, Mattia Boeri, Antonia Martinetti, Giuseppe Lo Russo, Rosaria Gallucci, Yasmina Modena, Anna Paola Fraccon, Luigi Cavanna, Barbara Formisano, Federico Nichetti, Emanuela Vattemi
Publikováno v:
Journal of Clinical Oncology. 36:e21101-e21101
e21101Background: Several studies have proven the efficacy of maintenance chemotherapy (CT) in advanced NSCLC. The use of low dose (i.e. metronomic) anti-mitotic drugs could exert an anti-angiogeni...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f52cf45d29c6965236c2f6d5228f04eb
https://doi.org/10.1200/jco.2018.36.15_suppl.e21101
https://doi.org/10.1200/jco.2018.36.15_suppl.e21101